Laboratorios Farma | ROVI - Ebit

Aktienkurs
80.00
Täglich Wechseln
0.15 0.19%
Monatlich
1.85%
Jährlich
51.80%
Q1 Prognose
76.74




Ebit Veränderung Datum
Akebia Therapeutics USD 13.51M 27.82M 2025-03
Alaunos Therapeutics USD -1.19M 148K 2025-09
Almirall EUR 30.23M 12.8M 2025-12
Avita Medical AUD -10.39M 1.72M 2025-12
Dianthus Therapeutics USD -40.29M 5.36M 2025-09
Ionis Pharmaceuticals USD -215M 54.82M 2025-12
IQVIA Holdings USD 2.68B 2.1B 2025-12
Laboratorios Farma EUR 135.05M 49.84M 2023-12
Moderna USD -857M 597M 2025-12
Organon & Co USD 388M 28M 2025-09
Pharma Mar EUR 43.61M 47.57M 2025-12
Revvity USD 145.83M 47.49M 2025-12
Tectonic Therapeutic USD -22.33M 4.03M 2025-06
Viatris USD -157.5M 392M 2025-12
Xeris Pharmaceuticals USD 7.89M 2.46M 2025-09